Portfolio Companies News
November 16, 2017Wilson Therapeutics to host confere...
Nov 16, 2017 On November 23, 2017, at 08:00 CET, Wilson Therapeutics will publish its interim report for the third quarter 2017. All interested parties are invited to participate in a web-cast telephone conference, which will include a presentation, on the same day at 10:00 CET. The eve... read more
November 14, 2017Strongbridge Biopharma plc Provides...
~ Achieved Net Product Sales of $2.5 Million for KEVEYIS®(dichlorphenamide), a 67% Revenue Growth Increase over the Previous Quarter ~ ~ Increasing Commercial Investment in KEVEYIS with Expansion of Sales Force and Launch of Genetic Testing Program ~ ~ RECORLEV™ (levoketoconazole) Phase 3 To... read more
November 14, 2017Bonesupport - Cerament® G’s pote...
Lund, Sweden, 08.00 CET, 14 November 2017 – BONESUPPORT, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform announces the publication of a paper ... read more
November 14, 2017Targovax to present at upcoming inv...
Tuesday, November 14, 2017 Oslo, Norway, 14 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at the following life sciences and investor c... read more
November 13, 2017Nexstim gains FDA clearance to comm...
13 November 2017 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces that the Food and Drug Administration (“FDA... read more
November 13, 2017Q3 2017 General Market Overview
Since the start in 1996, HealthCap funds have invested in 109 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
24 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.